Matches in DBpedia 2015-10 for { ?s ?p "Basmisanil (INN) (developmental code names RG-1662, RO5186582) is a highly selective inverse agonist/negative allosteric modulator of α5 subunit-containing GABAA receptors which is under development by Roche for the treatment of cognitive impairment associated with Down syndrome. As of May 2014, it is in phase II clinical trials for this indication."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Basmisanil abstract "Basmisanil (INN) (developmental code names RG-1662, RO5186582) is a highly selective inverse agonist/negative allosteric modulator of α5 subunit-containing GABAA receptors which is under development by Roche for the treatment of cognitive impairment associated with Down syndrome. As of May 2014, it is in phase II clinical trials for this indication.".
- Basmisanil comment "Basmisanil (INN) (developmental code names RG-1662, RO5186582) is a highly selective inverse agonist/negative allosteric modulator of α5 subunit-containing GABAA receptors which is under development by Roche for the treatment of cognitive impairment associated with Down syndrome. As of May 2014, it is in phase II clinical trials for this indication.".